On termination of trading in ordinary shares of RAPT Therapeutics, Inc. (RAPTold) and ordinary shares of FibroGen, Inc. (FGENold)
Effective June 20, 2025 ITS Ltd. shall terminate trading in the following Qualified Investments:
|
No |
Issuer`s Full Name |
Security Category and Type |
Identification code |
ISIN |
|
1 |
RAPT Therapeutics, Inc. |
ordinary share |
RAPTold |
US75382E1091 |
|
2 |
FibroGen, Inc. |
ordinary share |
FGENold |
US31572Q8087 |
The decision to exclude these Qualified Investments from the list of qualified investments admitted to trading was made in connection with the QI Consolidation (reverse split).